ArticleInternational urology and nephrology2026
Comment on "Assessing the real-world safety of sparsentan for immunoglobulin A nephropathy: insights from a comprehensive analysis of FAERS database".
Fan Wenjie et al.PubMed ↗Publisher ↗
No numbers read from the abstract.